Fiorentino and colleagues in 2013 confirmed this association in 37 anti-NXP2-positive patients with DM: at multivariate analysis, cancer was associated with either NXP2 or TIF1gamma antibodies, older age, and male sex [15]. Here, TRIM33 is linked to dermatomyositis.